1. Kuo PH, Huang KH, Lee CW, Lee WJ, Chen SJ, Liu KL. Emphysematous prostatitis caused by K. pneumoniae. J Formos Med Assoc. 2007. 106:74–77.
2. Bae GB, Kim SW, Shin BC, Oh JT, Do BH, Park JH, Lee JM, Kim NS. Emphysematous prostatic abscess due to
K. pneumoniae: report of a case and review of the literature. J Korean Med Sci. 2003. 18:758–760.
Article
3. Bartkowski DP, Lanesky JR. Emphysematous prostatitis and cystitis secondary to Candida albicans. J Urol. 1988. 139:1063–1065.
4. Thorner DA, Sfakianos JP, Cabrera F, Lang EK, Colon I. Emphysematous prostatitis in a diabetic patient. J Urol. 2010. 183:2025.
Article
5. Sampathkumar K, Murali TR, Sooraj YS, Mahaldar AR. Emphysematous prostatitis in renal transplant. Indian J Urol. 2007. 23:476–478.
Article
6. Chung DR, Lee SS, Lee HR, Kim HB, Choi HJ, Eom JS, Kim JS, Choi YH, Lee JS, Chung MH, Kim YS, Lee H, Lee MS, Park CK. Korean Study Group for Liver Abscess. Emerging invasive liver abscess caused by K1 serotype
K. pneumoniae in Korea. J Infect. 2007. 54:578–583.
Article
7. Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, McCormack JG, Yu VL. Community-acquired
K. pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis. 2002. 8:160–166.
Article
8. Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW. Community-acquired versus nosocomial
K. pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci. 2006. 21:816–822.
Article
9. Nadasy KA, Domiati-Saad R, Tribble MA. Invasive K. pneumoniae syndrome in North America. Clin Infect Dis. 2007. 45:e25–e28.
10. Cheng DL, Liu YC, Yen MY, Liu CY, Wang RS. Septic metastatic lesions of pyogenic liver abscess. Their association with
K. pneumoniae bacteremia in diabetic patients. Arch Intern Med. 1991. 151:1557–1559.
Article
11. Tsay RW, Siu LK, Fung CP, Chang FY. Characteristics of bacteremia between community-acquired and nosocomial
K. pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. Arch Intern Med. 2002. 162:1021–1027.
Article
12. Lee HC, Chuang YC, Yu WL, Lee NY, Chang CM, Ko NY, Wang LR, Ko WC. Clinical implications of hypermucoviscosity phenotype in
K. pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia. J Intern Med. 2006. 259:606–614.
Article
13. Kawai T. Hypermucoviscosity: an extremely sticky phenotype of
K. pneumoniae associated with emerging destructive tissue abscess syndrome. Clin Infect Dis. 2006. 42:1359–1361.
Article
14. Ma LC, Fang CT, Lee CZ, Shun CT, Wang JT. Genomic heterogeneity in
K. pneumoniae strains is associated with primary pyogenic liver abscess and metastatic infection. J Infect Dis. 2005. 192:117–128.
Article
15. Yang CC, Yen CH, Ho MW, Wang JH. Comparison of pyogenic liver abscess caused by non-K. pneumoniae and K. pneumoniae. J Microbiol Immunol Infect. 2004. 37:176–184.
16. Fung CP, Chang FY, Lee SC, Hu BS, Kuo BI, Liu CY, Ho M, Siu LK. A global emerging disease of
K. pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut. 2002. 50:420–424.
Article
17. Fang CT, Chuang YP, Shun CT, Chang SC, Wang JT. A novel virulence gene in
K. pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med. 2004. 199:697–705.
Article
18. Lederman ER, Crum NF. Pyogenic liver abscess with a focus on
K. pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol. 2005. 100:322–331.
Article